Table of Contents
A Milestone That Sounds Bureaucratic and Is Not
Nationwide provider licensure is the kind of achievement that tends to get described in the flattest possible terms: a company has secured the ability to operate, and its providers are licensed, across all fifty states. Framed that way, it sounds like a regulatory checkbox, the kind of operational milestone that matters to a company’s legal team and almost no one else.
Myra Ahmad, the founder and CEO of Mochi Health, has pushed back on that framing directly. In her account, nationwide licensure is not primarily a compliance achievement.
It is an access achievement, and the distinction matters because it changes who the milestone is actually for. A compliance story is about the company. An access story is about the patient who, until that licensure was in place, simply could not get treated at all.
Myra Ahmad on What Licensure Actually Gates for a Patient
The reason licensure functions as an access barrier rather than a paperwork detail is straightforward: a physician generally has to be licensed in the state where a patient is physically located at the time of treatment, not just the state where the company is headquartered or where the platform is built.
A telehealth company without licensure in a given state cannot legally treat a patient who lives there, no matter how strong its platform or how many providers it employs elsewhere.
That means a patient’s access to care under this model is not determined by their health needs, their motivation to seek treatment, or their ability to pay.
It is determined by whether the company they want to use happens to have secured a license in their specific state. A patient in a state without licensure is simply locked out, regardless of anything else about their situation.
Mochi Health’s push toward broader licensure is aimed directly at closing that gap, working to make health based outcomes available to everyone in the United States rather than leaving access dependent on geography.
Why Rural and Underserved States Have the Most at Stake
The states where licensure gaps matter most are frequently the same states with the thinnest existing healthcare infrastructure. Fewer specialists, longer drive times to a clinic, longer waits for an appointment once a patient gets there.
For a patient in a well-served metropolitan area, the absence of one telehealth company’s license in their state is an inconvenience, since alternatives likely exist nearby.
For a patient in a rural or medically underserved state, that same licensing gap can mean the difference between getting treated for a chronic condition and not getting treated at all.
Myra Ahmad’s framing of licensure as an access issue is sharpest in exactly these cases. A regulatory achievement that reads as routine from inside a company’s legal department can represent, from a patient’s side, the first realistic path to a physician who treats their specific condition seriously, delivered without the multi-hour drive or multi-month wait that the alternative would require.
The Slower, Less Visible Work Behind the Milestone
Nationwide licensure is the cumulative result of state-by-state regulatory work, medical board applications, and compliance requirements that vary from state to state and have to be satisfied individually.
That process is slow, unglamorous, and largely invisible to patients until it is complete, which is part of why it gets described in compliance terms rather than patient terms.
The work itself looks like paperwork. The outcome is a patient who now has somewhere to go.
That mismatch between how the milestone looks from the inside and what it means from the outside is exactly what Ahmad’s framing is meant to correct.
The states added to a licensure map are not abstractions on a compliance dashboard. Each one represents patients who previously had no legal path to treatment through the platform and now do.
Why Myra Ahmad’s Framing Matters Beyond One Company
The access argument behind nationwide licensure has implications that extend past Mochi Health’s own growth. If licensure gaps are genuinely a healthcare access problem, that argument applies to every telehealth company still working through the same state-by-state process.
A system where a patient’s access to a specific treatment depends on which state they happen to live in is a structural gap regardless of which company is trying to close it.
Ahmad’s positioning treats closing that gap, one state at a time if that is what the current regulatory system requires, as core to what a healthcare company aiming for genuine access is supposed to do, not a background compliance task to be handled quietly while the real story happens elsewhere.
What Full Nationwide Access Would Actually Mean
The end state Ahmad has described is straightforward to state and difficult to reach: a healthcare platform where a patient’s ability to get treated depends entirely on their willingness to seek care, not on which state they happen to call home.
Getting there requires finishing the state-by-state work that nationwide licensure demands, which is neither fast nor particularly newsworthy on a state-by-state basis.
But the cumulative effect of that unglamorous work is what makes the access argument real rather than aspirational. Every additional state where Mochi Health secures full licensure is, in practical terms, a state where a patient who previously had no legal path to this kind of care now has one.
That is the measure Ahmad has argued the milestone should actually be judged by, not whether the compliance paperwork is complete, but whether a real patient in a real state can now get treated who could not before.
Why the Comparison to Other Industries Falls Short
It is tempting to compare healthcare licensure to other kinds of regulatory patchworks, insurance rules that vary by state, tax codes that differ from one jurisdiction to the next, and treat nationwide expansion as simply another operational hurdle every growing company eventually clears.
That comparison undersells what is actually at stake in healthcare specifically. A retailer facing a state-by-state tax difference can usually still sell its product everywhere while it works out the details. A telehealth company without a physician license in a given state cannot legally treat a single patient there, full stop, until that license is secured.
That is a categorical difference, not a matter of degree. It is the reason Ahmad has resisted treating licensure as a routine expansion milestone comparable to opening a new office or launching in a new market in a typical consumer business. In healthcare, the regulatory gate is also the access gate, and closing it state by state is the only way patients in that state gain a legal path to treatment at all.
